Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic LeukemiaWilliam G. Wierda, Anders Österborg, Thomas J. Kipps et al.|Journal of Clinical Oncology|2010Cited by 587
Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)Elżbieta Iskierka‐Jazdzewska, Krzysztof Jamroziak, Jan Maciej Zaucha et al.|Leukemia & lymphoma/Leukemia and lymphoma|2017Cited by 39